Abstract
Nicotinamide adenine dinucleotide (NAD(+)) is an essential cofactor for hundreds of biochemical reactions. Targeting NAD(+) metabolism has been investigated as a therapeutic strategy for various metabolic, neurogenerative, and inflammatory conditions, including aging and cancer. Here we highlight recent advances in host-microbiome interactions regulating NAD(+) metabolism and discuss their therapeutic potential.